While the pharma industry won a victory in U.S. court this week on off-label marketing, in the European Union, drugmakers weren't so lucky. The EU's top court upheld a $69 million fine against AstraZeneca ($AZN), in a long-running antitrust case. The court's backing lends weight to antitrust officials' ongoing probe of the entire pharma industry.
Merck and AstraZeneca have opted for a little more togetherness. The two companies amended their marketing-and-supply arrangement on the stomach drugs Prilosec and Nexium, allowing Merck to continue booking profits from sales of the two drugs for at least two more years.
Public Citizen is petitioning the FDA for a "black box" warning on common stomach acid drugs such as AstraZeneca's ( $AZN ) Nexium and Prilosec and Pfizer's ( $PFE ) Protonix. The consumer watchdog group
AstraZeneca and Medco Health Solutions are under the Department of Justice's microscope. Prosecutors have subpoenaed the drugmaker and pharmacy benefits manager about their relationship, asking
Over-the-counter heartburn drugs don't need a new fracture-risk warning, the FDA says. When used at low doses and on a short-term basis, OTC versions of meds such as Prilosec and Prevacid don't
If you were doubting its word on the dangers of combining Plavix with Prilosec, the FDA plans to send out a reminder. As the Wall Street Journal reports, agency officials worry that a recently
Chalk up a victory for E.U. antitrust regulators. The General Court has ruled against AstraZeneca in an appeal, affirming the antitrust watchdog's finding that the drugmaker abused its dominant
Here's a test case for you: Procter & Gamble is launching a social media initiative for Prilosec as part of its bid to maintain the drug's leadership position in an increasingly crowded market.
The latest news about stomach drugs could give Plavix users a serious case of heartburn. The FDA shocked folks at the American Heart Association meeting with a warning that using the heartburn meds
Patients with heartburn, GERD, peptic ulcers or other conditions who take proton pump inhibitors to relieve symptoms are at increased risk of fractures, according to a large new study of patients